NGM, Janssen sign diabetes research partnership
Both the companies will work together to evaluate selected protein factors identified by NGM in order to progress the development of potent candidates with glucoregulatory effects of bariatric
Vertex has signed a definitive agreement to purchase Crinetics Pharmaceuticals in a transaction valued at nearly $10bn, or $8.8bn net of estimated cash acquired.